Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (151-160 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 5, 2012
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterizationIlenia Minicocci, Anna Montali, Marius Robert Robciuc, et al.
Journal of Lipid Research|April 5, 2016
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolismIlenia Minicocci, Anna Tikka, Eleonora Poggiogalle, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 31, 2025
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA)Alberto Zambon, Luigi Gentile, Federica Galimberti, et al.
Atherosclerosis|May 13, 2022
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric groupCristina Pederiva, Maria Elena Capra, Giacomo Biasucci, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Journal of the American Heart Association|April 23, 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsLaura D'Erasmo, Ilenia Minicocci, Alessia Di Costanzo, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 6, 2023
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines AgencyPiotr Szymański, Franz Weidinger, Isabelle Lordereau-Richard, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia SyndromeErik S G Stroes, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.
Journal of the Endocrine Society|November 29, 2019
Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical ProfilesLouis St L O'Dea, James MacDougall, Veronica J Alexander, et al.
Journal of Clinical Lipidology|January 4, 2021
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in ItalyGianfranco Mitacchione, Marco Schiavone, Antonio Curnis, et al.
Pageof 22

Showing results (151-160 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Endocrinology and Metabolism|June 5, 2012
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterizationIlenia Minicocci, Anna Montali, Marius Robert Robciuc, et al.
Journal of Lipid Research|April 5, 2016
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolismIlenia Minicocci, Anna Tikka, Eleonora Poggiogalle, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 31, 2025
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA)Alberto Zambon, Luigi Gentile, Federica Galimberti, et al.
Atherosclerosis|May 13, 2022
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric groupCristina Pederiva, Maria Elena Capra, Giacomo Biasucci, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Journal of the American Heart Association|April 23, 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsLaura D'Erasmo, Ilenia Minicocci, Alessia Di Costanzo, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 6, 2023
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines AgencyPiotr Szymański, Franz Weidinger, Isabelle Lordereau-Richard, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia SyndromeErik S G Stroes, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.
Journal of the Endocrine Society|November 29, 2019
Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical ProfilesLouis St L O'Dea, James MacDougall, Veronica J Alexander, et al.
Journal of Clinical Lipidology|January 4, 2021
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in ItalyGianfranco Mitacchione, Marco Schiavone, Antonio Curnis, et al.
Pageof 22